Skip to main content
. 2015 Jun 2;135(1):42–50. doi: 10.3109/00016489.2014.952047

Table I.

Major symptom score (MSS) from visit 1 (day 1) to visit 5 (day 14): FAS and PP.

  FAS
PP
MSS by visit BNO 1016 480 mg (n = 294) Placebo (n = 295) BNO 1016 480 mg (n = 213) Placebo (n = 220)
Visit 1 (day 0) Mean (SD) 10.02 (1.61) 9.87 (1.52) 9.70 (1.28) 9.65 (1.27)
Visit 2 (day 3) Mean (SD) 7.71 (2.40) 7.86 (2.71) 7.50 (2.11) 7.78 (2.53)
Visit 3 (day 7) Mean (SD) 5.54 (2.74) 6.15 (3.13) 5.15 (2.45) 6.14 (3.06)
Visit 4 (day 10) Mean (SD) 4.11 (2.66) 5.05 (3.44) 3.77 (2.32) 4.93 (3.42)
Visit 5 (day 14)*† Mean (SD) 2.47 (2.55) 3.63 (3.63) 2.06 (2.31) 3.76 (3.76)
p value*† p < 0.0001 p < 0.0001
Difference [placebo – BNO 1016 480 mg] (SD) 1.17 (3.14) 1.70 (3.13)

*One-sided; alpha = 0.025.

†ANCOVA.

FAS, full analysis set; PP, per-protocol population; SD, standard deviation.